User banner image
User avatar
  • admin

Posts

EKA Mobility Achieves 5x Volume Growth

PUNE, India, April 2, 2026 /PRNewswire/ — EKA Mobility, a leading electric vehicles and technology company, today announced a strong 5X year-on-year volume growth in...

New global report reveals men and young adults driving soaring usage of wellness technologies

●BON CHARGE™ Global Wellness Tech Trend Report highlights the rise of red light therapy, blue-light blocking devices, infrared sauna and PEMF tools Sydney, April 01,...

MiniLuxe Announces Follow-On Investment of up to US$1.75M from Flow Capital

Company expands on its relationship with Flow Capital. Boston, MA, April 01, 2026 (GLOBE NEWSWIRE) — MiniLuxe Holding Corp. (TSXV: MNLX)(“MiniLuxe” or the “Company”), the...

Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx

WALTHAM, Mass., April 01, 2026 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on the development and commercialization of innovative medicines that...

Stryker to announce financial results for its first quarter of fiscal year 2026

Portage, Michigan, April 01, 2026 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) announced that it will report financial results for its first quarter of fiscal year 2026...

RemoniHealth Expands Hardware-Free “Vision-as-a-Service” Platform to Cover Over 90% of Chronic Eye Diseases

Exclusive licensing of new breakthrough, clinic-grade tests to the RemoniHealth platform, solidifies its position as the only integrated RPM and PCM solution for population eye...

electroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSD

ROCKAWAY, N.J., April 01, 2026 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the publication of new...

Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST)

Bezuclastinib NDA submitted under the FDA’s RTOR program based on positive results from Phase 3 PEAK trial; bezuclastinib previously granted Breakthrough Therapy Designation in GIST...

Pizza Hut UK Asks the Nation to Say “I Do” to Free Pizza!

•More Brits (34%) say that a takeaway is more satisfying than a date (29%).• Over half (58%) are sceptical of the word “FREE” but Pizza...

PMET Resources Submits Environmental and Social Impact Assessment (ESIA) for the Shaakichiuwaanaan CV5 Lithium Project to Federal and Provincial Governments

MONTREAL, April 1, 2026 /PRNewswire/ — April 1, 2026 – Sydney, Australia HIGHLIGHTS ESIA Submission: PMET Resources (“PMET” or the “Company”) has submitted its Environmental...